Turnstone Biologics Corp. (TSBX)
NASDAQ: TSBX · Real-Time Price · USD
0.3341
-0.0058 (-1.71%)
At close: May 12, 2025, 4:00 PM
0.3400
+0.0059 (1.77%)
After-hours: May 12, 2025, 6:15 PM EDT
Turnstone Biologics Market Cap
Turnstone Biologics has a market cap or net worth of $7.73 million as of May 12, 2025. Its market cap has decreased by -89.11% in one year.
Market Cap
7.73M
Enterprise Value
-20.01M
1-Year Change
-89.11%
Ranking
Category
Stock Price
$0.33
Market Cap Chart
Since the IPO on July 21, 2023, Turnstone Biologics's market cap has decreased from $255.86M to $7.73M, a decrease of -96.98%. That is a compound annual growth rate of -85.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 7.86M | -31.57% |
| Dec 31, 2024 | 11.49M | -80.45% |
| Dec 29, 2023 | 58.77M | -77.03% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |